Martin Pharmaceuticals Receives FDA Orphan Drug Designation for LIVANTRA™
2026-08-18
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Dow Chemical’s Freeport Plant Fire Contained; No Injuries Reported
-
EU Clears Bayer-KWS Sugar Beet Event
-
EU Clears Bayer-KWS Sugar Beet Event
-
India Terminates Anti-Dumping Investigation on Chinese Siloxane Polyoxyalkylene Copolymers
-
INEOS Plant Closures Deepen Europe’s Chemical Industry Crisis
-
BioNTech’s Founders Turn the Page
-
Novo Nordisk Faces a Compliance Test
-
Deméter Enters China with a Stress-Focused Pitch
-
LANXESS Raises Global 1,6-Hexanediol Prices by 20% as Cost Pressure Begins to Pass Downstream
-
Roche Takes Natco to Supreme Court Over Generic Risdiplam Launch in India
Recommend Reading
-
Evonik Launches Advanced Gas-Phase Alumina Plant in Japan
-
Röhm Launches New Sulfuric Acid Plant
-
BASF Reports Modest Third Quarter Decline Amid Global Market Caution
-
Clariant SynDane Catalyst Performs Excellently at Wanhua Maleic Anhydride Plant
-
Evonik Achieves Successful Trial Production at Shanghai Polyamide Plant
-
This Week's PVC Price Range Adjustment (8.11-15) in China
-
This Week's Caustic Soda Prices Increased (8.11-8.15)
-
Bullish Support, Hydrogen Peroxide Prices Rise in China
-
Raw Materials Strengthen; PC Prices Show Volatility with a Rise at Late January
-
This Week TDI Market Focus Shifts Downward (8.11-8.15) in China